| Application no. and date | 20800617.1 (espacenet) (Federated) (European Patent Register), 20201030 | | Patent/reg. no. and date | DK/EP 4054582, 20250903 | | Publication date | 20220914 | | Priority no. and date | US 201962930208 P, 20191104 | | EP pub. no. and date |
EP 4054582 20220914 | | Effective date | | | Applicant/owner | Astrazeneca AB, 151 85 Södertälje, SE | | Applicant ref. no. | BB373998EPDK | | Inventor | DRY, Hannah, AstraZeneca Pharmaceuticals LP, 1800 Concord Pike,
P.O. Box 15437
Wilmington, Delaware 19850-5437, US,
WILLIS, Brandon, AstraZeneca Pharmaceuticals LP, 1800 Concord Pike,
P.O. Box 15437
Wilmington, Delaware 19850-5437, US,
BLOECHER, Andrew, AstraZeneca Pharmaceuticals LP, 1800 Concord Pike,
P.O. Box 15437
Wilmington, Delaware 19850-5437, US,
METTETAL, Jerome, AstraZeneca Pharmaceuticals LP, 1800 Concord Pike,
P.O. Box 15437
Wilmington, Delaware 19850-5437, US | | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | | Opponent | | | IPC Class | A61K 31/4985 (2006.01) , A61K 31/519 (2006.01) , A61P 35/00 (2006.01) | | Title | TERAPEUTISKE KOMBINATIONER AF ACALABRUTINIB OG CAPIVASERTIB TIL BEHANDLING AF B-CELLE-MALIGNITETER | | Int. application no. | EP2020080493 | | Int. publication no. | WO2021089419 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
